Skip to main content

Fish, n-3 Polyunsaturated Fatty Acids, and Cardiovascular Disease

  • Chapter
  • First Online:

Part of the book series: Nutrition and Health ((NH))

Abstract

Cardiovascular disease (CVD) is a major cause of morbidity and mortality in the western world [1]. There are a number of well-established risk factors for CVD including smoking, hypertension, and family history [2]. In terms of nutrition, a diet high in fat, particularly saturated fat, has been shown to be associated with CVD incidence [3]. The observation that Greenland Eskimos (Inuit) have a low incidence of CVD despite a high saturated fat intake [4] has led to much scientific and public interest in the role of n-3 fatty acids found in fish and fish oils in the prevention and treatment of disease, and particularly CVD. In this chapter, the biochemistry and normal dietary intake of these compounds will be discussed, and the evidence linking them and their food sources with CVD reviewed. The safety of both fish oil supplements and fish will be assessed, and finally the potential effect of fish and fish oil consumption on other diseases considered.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Ross R. The pathogenesis of atherosclerosis in a perspective for the 1990’s. Nature. 1993;362:801–9.

    PubMed  CAS  Google Scholar 

  2. Heller RF, Chinn S, Tunstall-Pedoe H, Rose G. How well can we predict coronary heart disease? Findings in the United Kingdom Heart Disease Prevention Project. Br Med J. 1984;288:1409–11.

    CAS  Google Scholar 

  3. Mann JI. Diet and risk of coronary heart disease and type 2 diabetes. Lancet. 2002;360:783–9.

    PubMed  CAS  Google Scholar 

  4. Dyerberg J, Bang HO. Haemostatic function and platelet polyunsaturated fatty acids in Eskimos. Lancet. 1979;2:433–5.

    PubMed  CAS  Google Scholar 

  5. Emken EA, Adlof RO, Gulley RM. Dietary linoleic acid influences desaturation and acylation of deuterium-labelled linoleic and linolenic acids in young adult males. Biochim Biophys Acta. 1994;1213:277–88.

    PubMed  CAS  Google Scholar 

  6. Pawlosky RJ, Hibbeln JR, Novotny JA, Salem Jr N. Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans. J Lipid Res. 2001;42:1257–65.

    PubMed  CAS  Google Scholar 

  7. Ministry of Agriculture, Fisheries and Food. Fatty acids. Seventh supplement to the fifth edition of McCance and Widdowson’s The Composition of Foods. London: HMSO; 1998.

    Google Scholar 

  8. Kromhout D, Bosschieter EB, de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med. 1985;312:1205–9.

    PubMed  CAS  Google Scholar 

  9. Kromhout D, Feskens EJ, Bowles CH. The protective effect of a small amount of fish on coronary heart disease mortality in an elderly population. Int J Epidemiol. 1995;24:340–5.

    PubMed  CAS  Google Scholar 

  10. Shekelle RB, Missell L, Paul O, Shryock AM, Stamler J. Fish consumption and mortality from coronary heart disease. N Engl J Med. 1985;313:820–4.

    Google Scholar 

  11. Dolecek TA, Granditis G. Dietary polyunsaturated fatty acids and mortality in the Multiple Risk Factor Intervention Trial (MRFIT). World Rev Nutr Diet. 1991;66:205–16.

    PubMed  CAS  Google Scholar 

  12. Daviglus ML, Stamler J, Orencia AJ, et al. Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med. 1997;336:1046–53.

    PubMed  CAS  Google Scholar 

  13. Lemaitre RN, King IB, Mozaffarian D, Kuller LH, Tracy RP, Siscovick DS. N-3 polyunsaturated fatty acids, fatal ischemic disease, and nonfatal myocardial infarction in older adults: the Cardiovascular Health Study. Am J Clin Nutr. 2003;77:319–25.

    PubMed  CAS  Google Scholar 

  14. Whelton SP, He J, Whelton PK, Muntner P. Meta-analysis of observational studies on fish intake and coronary heart disease. Am J Cardiol. 2004;93:1119–23.

    PubMed  Google Scholar 

  15. Mente A, de Koning L, Shannon HS, Anand SS. A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med. 2009;169:659–69.

    PubMed  CAS  Google Scholar 

  16. Marckmann P, Gronbaek M. Fish consumption and coronary heart disease mortality: a systematic review of prospective cohort studies. Eur J Clin Nutr. 1999;53:585–90.

    PubMed  CAS  Google Scholar 

  17. He K, Song Y, Daviglus ML, et al. Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies. Circulation. 2004;109:2705–11.

    PubMed  Google Scholar 

  18. Zhang J, Sasaki S, Amano K, Kestelot H. Fish consumption and mortality from all causes, ischemic heart disease, and stroke: an ecological study. Prev Med. 1999;28:520–9.

    PubMed  CAS  Google Scholar 

  19. Ascherio A, Rimm EB, Stampfer MJ, Giovannucci EL, Willett WC. Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary heart disease among men. N Engl J Med. 1995;332:977–82.

    PubMed  CAS  Google Scholar 

  20. Albert CM, Hennekens CH, O’Donnell CJ, et al. Fish consumption and risk of sudden cardiac death. JAMA. 1998;279:23–8.

    PubMed  CAS  Google Scholar 

  21. Kromhout D, Bloemberg BP, Feskens EJ, Hertog MG, Menotti A, Blackburn H. Alcohol, fish, fibre and antioxidant vitamin intake do not explain population differences in coronary heart disease mortality. Int J Epidemiol. 1996;25:753–9.

    PubMed  CAS  Google Scholar 

  22. Pietinen P, Ascherio A, Korhonen P, et al. Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men: the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Epidemiol. 1997;145:876–87.

    PubMed  CAS  Google Scholar 

  23. Kris-Etherton PM, Harris WS, Appel LJ, for the Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 2002;106:2747–57.

    Google Scholar 

  24. Kromhout D. Fish consumption and sudden cardiac death. JAMA. 1998;279:65–6.

    PubMed  CAS  Google Scholar 

  25. Sheard NF. Fish consumption and risk of sudden cardiac death. Nutr Rev. 1998;56:177–9.

    PubMed  CAS  Google Scholar 

  26. Oomen CM, Feskens EJ, Rasanen L, et al. Fish consumption and coronary heart disease mortality in Finland, Italy and the Netherlands. Am J Epidemiol. 2000;151:999–1006.

    PubMed  CAS  Google Scholar 

  27. Salonen JT, Seppanen K, Lakka TA, Salonen R, Kaplan GA. Mercury accumulation and accelerated progression of carotid atherosclerosis: a population-based prospective 4-year follow-up study in men in eastern Finland. Atherosclerosis. 2000;148:265–73.

    PubMed  CAS  Google Scholar 

  28. Ahlqwist M, Bengtsson C, Lapidus L, Gergdahl IA, Schutz A. Serum mercury concentration in relation to survival, symptoms, and diseases: results from the prospective population study of women in Gothenburg, Sweden. Acta Odontol Scand. 1999;57:168–74.

    PubMed  CAS  Google Scholar 

  29. Harris WS, Poston WC, Haddock CK. Tissue n-3 and n-6 fatty acids and risk for coronary heart disease events. Atherosclerosis. 2007;193:1–10.

    PubMed  CAS  Google Scholar 

  30. Burr ML, Fehily AM, Gilbert JF, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet and Reinfarction Trial (DART). Lancet. 1989;2:757–61.

    PubMed  CAS  Google Scholar 

  31. Burr ML, Sweetnam PM, Fehily AM. Diet and reinfarction. Eur Heart J. 1994;15:1152–3.

    PubMed  CAS  Google Scholar 

  32. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarcto miocardico. Lancet. 1999;354:447–55.

    Google Scholar 

  33. Nilsen DW, Albrektsen G, Landmark K, Moen S, Aarsland T, Woie L. Effects of a high dose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol. Am J Clin Nutr. 2001;74:50–6.

    PubMed  CAS  Google Scholar 

  34. Burr ML, Ashfield-Watt PAL, Dunstan FDJ, et al. Lack of benefit of dietary advice to men with angina: results of a controlled trial. Eur J Clin Nutr. 2003;57:193–200.

    PubMed  CAS  Google Scholar 

  35. Lavie CJ, Milani RV, Mehra MR, Ventura HO. Omega-3 polyunsaturated fatty acids and cardiovascular diseases. J Am Coll Cardiol. 2009;54:585–94.

    PubMed  CAS  Google Scholar 

  36. Rauch B, Schiele R, Schneider S, et al. OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction. Circulation. 2010;122:2152–9.

    PubMed  CAS  Google Scholar 

  37. Kromhout D, Giltay EJ, Geleijnse J, for the Alpha Omega Trial Group. n-3 Fatty acids and cardiovascular events after myocardial infarction. N Engl J Med. 2010;363:2015–26.

    Google Scholar 

  38. Yokoyama M, Origasa H, Matsuzaki M, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet. 2007;369:1090–8.

    PubMed  CAS  Google Scholar 

  39. von Schacky C, Harris WS. Cardiovascular benefits of omega-3 fatty acids. Cardiovasc Res. 2007;73:310–5.

    Google Scholar 

  40. Albert CM, Campos H, Stampfer MJ, et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med. 2002;346:1113–8.

    PubMed  CAS  Google Scholar 

  41. Siscovick DS, Raghunathan TE, King I, et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA. 1995;274:1363–7.

    PubMed  CAS  Google Scholar 

  42. Marchioli R, Barzi F, Bomba E, et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time course analysis of the results of the GISSI-Prevenzione. Circulation. 2002;105:1897–903.

    PubMed  CAS  Google Scholar 

  43. Leaf A, Kang JX, Xiao Y-F, Billman GE. Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation. 2003;107:2646–52.

    PubMed  Google Scholar 

  44. Bucher HC, Hengstler P, Schindler C, Meier G. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomised controlled trials. Am J Med. 2002;112:298–304.

    PubMed  CAS  Google Scholar 

  45. Lee JH, O’Keefe JH, Lavie CJ, Marchioli R, Harris WS. Omega-3 fatty acids for cardioprotection. Mayo Clin Proc. 2008;83:324–32.

    PubMed  CAS  Google Scholar 

  46. Marik PE, Varon J. Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review. Clin Cardiol. 2009;32:365–72.

    PubMed  Google Scholar 

  47. Wang C, Harris WS, Cheung M, et al. n-3 Fatty acids from fish or fish-oil supplements, but not α-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr. 2006;84:5–17.

    PubMed  CAS  Google Scholar 

  48. Mozaffarian D, Bryson CL, Lemaitre RN, et al. Fish intake and risk of incident heart failure. J Am Coll Cardiol. 2005;45:2015–21.

    PubMed  CAS  Google Scholar 

  49. Levitan EB, Wolk A, Mittleman MA. Fish consumption, marine omega-3 fatty acids, and incidence of heart failure: a population-based prospective study of middle-aged and elderly men. Eur Heart J. 2009;30:1495–500.

    PubMed  CAS  Google Scholar 

  50. Yamagishi J, Nettleton JA, Folsom AR. Plasma fatty acid composition and incident heart failure in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J. 2008;156:965–74.

    PubMed  CAS  Google Scholar 

  51. Yamagishi K, Iso H, Date C, et al. Fish, ω-3 polyunsaturated fatty acids, and mortality from cardiovascular diseases in a nationwide community-based cohort of Japanese men and women. J Am Coll Cardiol. 2008;52:988–96.

    PubMed  CAS  Google Scholar 

  52. GISSI-HF Investigators, Tavazzi L, Maggioni AP, Marchioli R, et al. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomized, double-blind, placebo-controlled trial. Lancet. 2008;372:1223–30.

    PubMed  Google Scholar 

  53. Moertl D, Hammer A, Steiner S, et al. Dose-dependent effects of omega-3 polyunsaturated fatty acids on systolic left ventricular function, endothelial function, and markers of inflammation in chronic heart failure of nonischemic origin: a double-blind, placebo-­controlled, 3-arm study. Am Heart J. 2011;161:915.e–9.

    Google Scholar 

  54. Skerrett PJ, Hennekens CH. Consumption of fish and fish oils and decreased risk of stroke. Prev Cardiol. 2003;6:38–41.

    PubMed  CAS  Google Scholar 

  55. Orencia AJ, Daviglus ML, Dyer AR, Shekelle RB, Stamler J. Fish consumption and stroke in men: 30-year findings of the Chicago Western Electric Study. Stroke. 1996;27:204–9.

    PubMed  CAS  Google Scholar 

  56. Morris MC, Manson JE, Rosner B, Buring JE, Willett WC, Hennekens CH. Fish consumption and cardiovascular disease in the Physicians’ Health Study: a prospective study. Am J Epidemiol. 1995;142:166–75.

    PubMed  CAS  Google Scholar 

  57. Iso H, Rexrode KM, Stampfer MJ, et al. Intake of fish and omega-3 fatty acids and risk of stroke in women. JAMA. 2001;285:304–12.

    PubMed  CAS  Google Scholar 

  58. Keli SO, Feskens EJ, Kromhout D. Fish consumption and risk of stroke: the Zutphen Study. Stroke. 1994;25:328–32.

    PubMed  CAS  Google Scholar 

  59. Gillum RF, Mussolino ME, Madans JH. The relationship between fish consumption and stroke incidence: the NHANES I Epidemiologic Follow-up Study. Arch Intern Med. 1996;156:537–42.

    PubMed  CAS  Google Scholar 

  60. He K, Rimm EB, Merchant A, et al. Fish consumption and risk of stroke in men. JAMA. 2002;288:3130–6.

    PubMed  CAS  Google Scholar 

  61. Mozaffarian D, Longstreth Jr WT, Lemaitre RN, et al. Fish consumption and stroke risk in elderly individuals: the cardiovascular health study. Arch Intern Med. 2005;165:200–6.

    PubMed  Google Scholar 

  62. Myint P, Welch AA, Bingham SA, et al. Habitual fish consumption and risk of incident stroke: the European Prospective Investigation into Cancer (EPIC)-Norfolk prospective population study. Public Health Nutr. 2006;9:882–8.

    PubMed  Google Scholar 

  63. Montonen J, Järvinen R, Reunanen A, Knekt P. Fish consumption and the incidence of cerebrovascular disease. Br J Nutr. 2009;102:750–6.

    PubMed  CAS  Google Scholar 

  64. de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction. Final report of the Lyon Diet Heart Study. Circulation. 1999;99:779–85.

    PubMed  Google Scholar 

  65. Tanaka K, Ishikawa Y, Yokoyama M, et al. Reduction in the recurrence of stroke by eicosapentaenoic acid for hypercholesterolemic patients. Stroke. 2008;39:2052–8.

    PubMed  CAS  Google Scholar 

  66. Charnock JS. Lipids and cardiac arrhythmia. Prog Lipid Res. 1994;33:355–85.

    PubMed  CAS  Google Scholar 

  67. Nair SSD, Leitch JW, Falconer J, Garg ML. Prevention of cardiac arrhythmia by dietary (n-3) polyunsaturated fatty acids and their mechanism of action. J Nutr. 1997;127:383–93.

    PubMed  CAS  Google Scholar 

  68. Anand RG, Alkadri M, Lavie CJ, Milani RV. The role of fish oil in arrhythmia prevention. J Cardiopulm Rehabil Prev. 2008;28:2–8.

    Google Scholar 

  69. Lee KW, Lip GYH. The role of omega-3 fatty acids in the secondary prevention of cardiovascular disease. Q J Med. 2003;96:465–80.

    CAS  Google Scholar 

  70. Raitt MH, Connor WE, Morris C, et al. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial. JAMA. 2005;293:2884–91.

    PubMed  CAS  Google Scholar 

  71. Leaf A, Albert CM, Josephson M, et al. Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation. 2005;112:2762–8.

    PubMed  CAS  Google Scholar 

  72. Brouwer IA, Zock PL, Camm AJ, et al. Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial. JAMA. 2006;295:2613–9.

    PubMed  CAS  Google Scholar 

  73. Jenkins DJ, Josse AR, Beyene J, et al. Fish-oil supplementation with implantable cardioverter defibrillators: a meta-analysis. CMAJ. 2008;178:157–64.

    PubMed  Google Scholar 

  74. Harris WS, Connor WE, Alam N, Illingworth DR. Reduction of postprandial triglyceridaemia in humans by dietary n-3 fatty acids. J Lipid Res. 1988;29:1451–60.

    PubMed  CAS  Google Scholar 

  75. Grimsgaard S, Bonaa KH, Hansen JB, Nordoy A. Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids. Am J Clin Nutr. 1997;66:649–59.

    PubMed  CAS  Google Scholar 

  76. Harris WS, Miller M, Tighe AP, Davidson MH, Schaefer EJ. Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis. 2008;197:12–24.

    PubMed  CAS  Google Scholar 

  77. Howe PR. Dietary fats and hypertension: focus on fish oil. Ann N Y Acad Sci. 1997;827:339–52.

    PubMed  CAS  Google Scholar 

  78. Geleijnse JM, Giltay EJ, Grobbee DE, Donders AR, Kok FJ. Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens. 2002;20:1493–9.

    PubMed  CAS  Google Scholar 

  79. Cicero AF, Ertek S, Borghi C. Omega-3 polyunsaturated fatty acids: their potential role in blood pressure prevention and treatment. Curr Vasc Pharmacol. 2009;7:330–7.

    PubMed  CAS  Google Scholar 

  80. Mori TA. Omega-3 fatty acids and hypertension in humans. Clin Exp Pharmacol Physiol. 2006;33:842–6.

    PubMed  CAS  Google Scholar 

  81. Agren JJ, Vaisanen S, Hanninen O, Muller AD, Hornstra G. Hemostatic factors and platelet aggregation after a fish-enriched diet or fish oil or docosahexaenoic acid supplementation. Prostaglandins Leukot Essent Fatty Acids. 1997;57:419–21.

    PubMed  CAS  Google Scholar 

  82. Mori TA, Beilin LJ, Burke V, Morris J, Ritchie J. Interactions between dietary fat, fish and fish oils and their effects on platelet function in men at risk of cardiovascular disease. Arterioscler Thromb Vasc Biol. 1997;17:279–86.

    PubMed  CAS  Google Scholar 

  83. He K. Fish, long-chain omega-3 polyunsaturated fatty acids and prevention of cardiovascular disease—eat fish or take fish oil supplement? Prog Cardiovasc Dis. 2009;52:95–114.

    PubMed  CAS  Google Scholar 

  84. Shahar E, Folsom AR, Wu KK, et al. Associations of fish intake and dietary n-3 polyunsaturated fatty acids with a hypocoagulable profile. The Atherosclerosis Risk in Communities (ARIC) study. Arterioscler Thromb. 1993;13:1205–12.

    PubMed  CAS  Google Scholar 

  85. Archer SL, Green D, Chamberlain M, Dyer AR, Liu K. Association of dietary fish and n-3 fatty acid intake with hemostatic factors in the coronary artery risk development in young adults (CARDIA) study. Arterioscler Thromb Vasc Biol. 1998;18:1119–23.

    PubMed  CAS  Google Scholar 

  86. Johansen O, Brekke M, Seljeflot I, Abdelnoor M, Arnesen H. N-3 fatty acids do not prevent restenosis after coronary angioplasty: results from the CART study. Coronary Angioplasty Restenosis Trial. J Am Coll Cardiol. 1999;33:1619–26.

    PubMed  CAS  Google Scholar 

  87. Marckmann P, Bladbjerg EM, Jespersen J. Dietary fish oil (4 g daily) and cardiovascular risk markers in healthy men. Arterioscler Thromb Vasc Biol. 1997;17:3384–91.

    PubMed  CAS  Google Scholar 

  88. Abe Y, El-Masri B, Kimball KT, et al. Soluble cell adhesion molecules in hypertriglyceridaemia and potential significance on monocyte adhesion. Arterioscler Thromb Vasc Biol. 1998;18:723–31.

    PubMed  CAS  Google Scholar 

  89. Seljeflot I, Arnesen H, Brude IR, Nenseter MS, Drevon CA, Hjermann I. Effects of omega-3 fatty acids and/or antioxidants on endothelial cell markers. Eur J Clin Invest. 1998;28:629–35.

    PubMed  CAS  Google Scholar 

  90. Thies F, Garry JMC, Yaqoob P, et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomized controlled trial. Lancet. 2003;361:477–85.

    PubMed  CAS  Google Scholar 

  91. Brown A, Hu F. Dietary modulation of endothelial function: implications for cardiovascular disease. Am J Clin Nutr. 2001;73:673–86.

    PubMed  CAS  Google Scholar 

  92. Skulas-Ray AC, Kris-Etherton PM, Harris WS, et al. Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia. Am J Clin Nutr. 2011;93:243–52.

    PubMed  CAS  Google Scholar 

  93. De Caterina R, Libby P. Control of endothelial leukocyte adhesion molecules by fatty acids. Lipids. 1996;31:S57–63.

    PubMed  Google Scholar 

  94. De Caterina R, Liao JK, Libby P. Fatty acid modulation of endothelial activation. Am J Clin Nutr. 2000;71:213S–23.

    PubMed  Google Scholar 

  95. Lopez-Garcia E, Schulze MB, Manson JE, et al. Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr. 2004;134:1806–11.

    PubMed  CAS  Google Scholar 

  96. He K, Liu K, Daviglus ML, et al. Associations of dietary long-chain n-3 polyunsaturated fatty acids and fish with biomarkers of inflammation and endothelial activation (from the Multi-Ethnic Study of Atherosclerosis [MESA]). Am J Cardiol. 2009;103:1238–43.

    PubMed  CAS  Google Scholar 

  97. Endres S, von Schacky C. n-3 Polyunsaturated fatty acids and human cytokine synthesis. Curr Opin Lipidol. 1996;7:48–52.

    PubMed  CAS  Google Scholar 

  98. Trebble TM, Wootton SA, Miles EA, et al. Prostaglandin E2production and T cell function after fish-oil supplementation: response to antioxidant cosupplementation. Am J Clin Nutr. 2003;78:376–82.

    PubMed  CAS  Google Scholar 

  99. Hjerkinn EM, Seljeflot I, Ellingsen I, et al. Influence of long-term intervention with dietary counseling, long-chain n-3 fatty acid supplements, or both on circulating markers of endothelial activation in men with long-standing hyperlipidemia. Am J Clin Nutr. 2005;81:583–9.

    PubMed  CAS  Google Scholar 

  100. Wall R, Ross RP, Fitzgerald GF, Stanton C. Fatty acids from fish: the anti-inflammatory potential of long chain omega-3 fatty acids. Nutr Rev. 2010;68:280–9.

    PubMed  Google Scholar 

  101. Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune disease. J Am Coll Nutr. 2002;21:495–505.

    PubMed  CAS  Google Scholar 

  102. Brouwer IA, Katan MB, Zock PL. Dietary alpha-linolenic acid is associated with reduced risk of fatal coronary heart disease, but increased prostate cancer risk: a meta-analysis. J Nutr. 2004;134:919–22.

    PubMed  CAS  Google Scholar 

  103. Djousse L, Folsom AR, Province MA, Hunt SC, Ellison RC. Dietary linolenic acid and carotid atherosclerosis: the National Heart, Lung and Blood Institute Family Heart Study. Am J Clin Nutr. 2003;77:819–25.

    PubMed  CAS  Google Scholar 

  104. Albert CM, Oh K, Whang W, et al. Dietary-linolenic acid intake and risk of sudden cardiac death and coronary heart disease. Circulation. 2005;112:3232–8.

    PubMed  CAS  Google Scholar 

  105. Campos H, Baylin A, Willett WC. α-Linolenic acid and risk of non-fatal acute myocardial infarction. Circulation. 2008;118:339–45.

    PubMed  CAS  Google Scholar 

  106. Natvig H, Borchgrevink CF, Dedichen J, Owren PA, Schiotz EH, Westlund K. A controlled trial of the effect of linolenic acid on the incidence of coronary heart disease. Scand J Clin Lab Med. 1968;105:S1–20.

    Google Scholar 

  107. Bemelmans WJ, Broer J, Feskens EJ, et al. Effect of an increased intake of alpha-linolenic acid and group nutritional education on cardiovascular risk factors: the Mediterranean Alpha-linolenic Enriched Groningen Dietary Intervention (MARGARIN) study. Am J Clin Nutr. 2002;75:221–7.

    PubMed  CAS  Google Scholar 

  108. Lee JH, O’Keefe JH, Lavie CJ, Harris WS. Omega-3 fatty acids: cardiovascular benefits, sources and sustainability. Nat Rev Cardiol. 2009;6:753–8.

    PubMed  CAS  Google Scholar 

  109. Scientific Advisory Committee on Nutrition. Advice on fish consumption: benefits and risks. London: Stationary Office; 2004. www.food.gov.uk/multimedia/pdfs/fishreport200401.pdf. Accessed 13 Sept 2010.

  110. Oken E, Belfort MB. Fish, fish oil, and pregnancy. JAMA. 2010;304:1717–8.

    PubMed  CAS  Google Scholar 

  111. Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: evaluating the risks and benefits. JAMA. 2006;296:1885–99.

    PubMed  CAS  Google Scholar 

  112. Horvath A, Koletzko B, Szajewska H. Effect of supplementation of women in high-risk pregnancies with long-chain polyunsaturated fatty acids on pregnancy outcomes and growth measures at birth: a meta-analysis of randomized controlled trials. Br J Nutr. 2007;98:253–9.

    PubMed  CAS  Google Scholar 

  113. Makrides M, Duley L, Olsen SF. Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by preeclampsia or intrauterine growth restriction. Cochrane Database Syst Rev. 2006;3:CD003402.

    Google Scholar 

  114. Mendez MA, Plana E, Guxens M, et al. Seafood consumption in pregnancy and infant size at birth: results from a prospective Spanish cohort. J Epidemiol Community Health. 2010;64:216–22.

    PubMed  Google Scholar 

  115. Oken E, Bellinger DC. Fish consumption, methylmercury and child neurodevelopment. Curr Opin Pediatr. 2008;20:178–83.

    PubMed  Google Scholar 

  116. Hibbeln JR, Davis JM, Steer C, et al. Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): an observational cohort study. Lancet. 2007;369:578–85.

    PubMed  Google Scholar 

  117. Terry PD, Rohan TE, Wolk A. Intakes of fish and marine fatty acids and the risks of cancers of the breast and prostate and of other hormone-related cancers: a review of the epidemiologic evidence. Am J Clin Nutr. 2003;77:532–43.

    PubMed  CAS  Google Scholar 

  118. Rose DP, Connolly JM. Omega-3 fatty acids as cancer chemopreventive agents. Pharmacol Ther. 1999;83:217–44.

    PubMed  CAS  Google Scholar 

  119. Szymanski KM, Wheeler DC, Mucci LA. Fish consumption and prostate cancer risk: a review and meta-analysis. Am J Clin Nutr. 2010;92:1223–33.

    PubMed  CAS  Google Scholar 

  120. MacLean CH, Newberry SJ, Mojica WA, et al. Effects of omega-3 fatty acids on cancer risk: a systematic review. JAMA. 2006;295:403–15.

    PubMed  CAS  Google Scholar 

  121. Fearon KC, Barber MD, Moses AG, et al. Double blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia. J Clin Oncol. 2006;24:3401–7.

    PubMed  CAS  Google Scholar 

  122. Dewey A, Baughan C, Dean TP, Higgins B, Johnson I. Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia. Cochrane Database Syst Rev. 2007;1:CD004597.

    Google Scholar 

  123. Friedland RP. Fish consumption and the risk of Alzheimer disease. Is it time to make dietary recommendations? Arch Neurol. 2003;60:923–4.

    PubMed  Google Scholar 

  124. Conquer JA, Tierney MC, Zecevic J, Bettger WJ, Fisher RH. Fatty acid analysis of blood plasma of patients with Alzheimer’s disease, other types of dementia, and cognitive impairment. Lipids. 2000;35:1305–12.

    PubMed  CAS  Google Scholar 

  125. Schaefer EJ, Bongard V, Beiser AS, et al. Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: The Framingham Heart Study. Arch Neurol. 2006;63:1545–50.

    PubMed  Google Scholar 

  126. Morris MC, Evans DA, Bienias J, et al. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol. 2003;60:940–6.

    PubMed  Google Scholar 

  127. Quinn JF, Raman R, Thomas RG, et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA. 2010;304:1903–11.

    PubMed  CAS  Google Scholar 

  128. Coon KD, Myers AJ, Craig DW. A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer’s disease. J Clin Psychiatry. 2007;68:613–8.

    PubMed  CAS  Google Scholar 

  129. Barberger-Gateau P, Raffaitin C, Letenneur L, et al. Dietary patterns and risk of dementia: the Three-City cohort study. Neurology. 2007;69:1921–30.

    PubMed  CAS  Google Scholar 

  130. Huang TL, Zandi PP, Tucker KL, et al. Benefits of fatty fish on dementia risk are stronger for those without APOE epsilon4. Neurology. 2005;65:1409–14.

    PubMed  CAS  Google Scholar 

  131. Rennie KL, Hughes J, Lang R, Jebb SA. Nutritional management of rheumatoid arthritis: a review of the evidence. J Hum Nutr Diet. 2003;16:97–109.

    PubMed  CAS  Google Scholar 

  132. Cleland LG, James MJ, Proudman SM. The role of fish oils in the treatment of rheumatoid arthritis. Drugs. 2003;63:845–53.

    PubMed  CAS  Google Scholar 

  133. Calder P. Joint Nutrition Society and Irish Nutrition and Dietetic Institute Symposium on ‘Nutrition and autoimmune disease’ PUFA, inflammatory process and rheumatoid arthritis. Proc Nutr Soc. 2008;67:409–18.

    PubMed  CAS  Google Scholar 

  134. Hu FB, Cho E, Rexrode KM, Albert CM, Manson JE. Fish and long-chain omega-3 fatty acid intake and risk of coronary heart disease and total mortality in diabetic women. Circulation. 2003;107:1852–7.

    PubMed  Google Scholar 

  135. Djousse L, Gaziano JM, Buring JE, Lee I-M. Dietary omega-3 fatty acids and fish consumption and risk of type 2 diabetes. Am J Clin Nutr. 2011;93:143–50.

    PubMed  CAS  Google Scholar 

  136. Vessby B, Karlsrom B, Boberg M, Lithell H, Berne C. Polyunsaturated fatty acids may impair blood glucose control in type 2 diabetic patients. Diabet Med. 1992;9:126–33.

    PubMed  CAS  Google Scholar 

  137. Hartweg J, Perera R, Montori VM, et al. Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus (review). Cochrane Database Syst Rev. 2008;1:CD003205.

    Google Scholar 

  138. Friedberg CE, Janssen MJ, Heine RJ, Grobbee DE. Fish oil and glycemic control in diabetes. A meta-analysis. Diabetes Care. 1998;21:494–500.

    PubMed  CAS  Google Scholar 

  139. Simopoulos AP. Evolutionary aspects of omega-3 fatty acids in the food supply. Prostaglandins Leukot Essent Fatty Acids. 1999;60:421–9.

    PubMed  CAS  Google Scholar 

  140. Harris WS, Ginsberg HN, Arunakul N, et al. Safety and efficacy of Omacor in severe hypertriglyceridaemia. J Cardiovasc Risk. 1997;4:385–91.

    PubMed  CAS  Google Scholar 

  141. De Deckere EAM. Health effects of fish and n-3 polyunsaturated fatty acids from plant and marine origin. In: Wilson T, Temple NJ, editors. Nutritional health: strategies for disease prevention. Totowa, NJ: Humana Press; 2001. p. 195–206.

    Google Scholar 

  142. Lox CD. The effects of dietary marine oils (omega-3 fatty acids) on coagulation profiles in men. Gen Pharmacol. 1990;21:241–6.

    PubMed  CAS  Google Scholar 

  143. Harris WS. N-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr. 1997;65:1645S–54.

    PubMed  CAS  Google Scholar 

  144. Hau MF, Smelt AH, Bindels AJ, et al. Effects of fish oil on oxidation resistance of VLDL in hypertriglyceridemic patients. Arterioscler Thromb Vasc Biol. 1996;16:1197–202.

    PubMed  CAS  Google Scholar 

  145. Sorensen NS, Marckmann P, Hoy CE, van Duyvenvoorde W, Princen HM. Effect of fish-oil-enriched margarine on plasma lipids, low-density-lipoprotein particle composition, size, and susceptibility to oxidation. Am J Clin Nutr. 1998;68:235–41.

    PubMed  CAS  Google Scholar 

  146. Brude IR, Drevon CA, Hjermann I, et al. Peroxidation of LDL from combined-hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants. Arterioscler Thromb Vasc Biol. 1997;17:2576–88.

    PubMed  CAS  Google Scholar 

  147. Bonanome A, Biasia F, De Luca M, et al. n-3 Fatty acids do not enhance LDL susceptibility to oxidation in hypertriacylglycerolemic hemodialyzed subjects. Am J Clin Nutr. 1996;63:261–6.

    PubMed  CAS  Google Scholar 

  148. Higdon JV, Du SH, Lee YS, Wu T, Wander RC. Supplementation of postmenopausal women with fish oil does not increase overall oxidation of LDL ex vivo compared to dietary oils rich in oleate and linoleate. J Lipid Res. 2001;42:407–18.

    PubMed  CAS  Google Scholar 

  149. Food Standards Agency. Dietary recommendations for fish and shellfish. http://tna.europarchive.org/20110116113217/cot.food.gov.uk/pdfs/fishreport2004full.pdf. Accessed 8 July 2011.

  150. SeaChoice. Canada’s seafood guide. http://www.seachoice.org. Accessed 15 Sept 2011.

  151. Lee DH, Jacobs DR. Inconsistent epidemiological findings on fish consumption may be indirect evidence of harmful contaminants in fish. J Epidemiol Community Health. 2010;64:190–2.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Claire McEvoy MPhil .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

McEvoy, C., Young, I.S., Woodside, J.V. (2012). Fish, n-3 Polyunsaturated Fatty Acids, and Cardiovascular Disease. In: Temple, N., Wilson, T., Jacobs, Jr., D. (eds) Nutritional Health. Nutrition and Health. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-894-8_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-61779-894-8_10

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61779-893-1

  • Online ISBN: 978-1-61779-894-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics